Opsona Therapeutics Raises €18 Million
Opsona Therapeutics, a Dublin, Ireland-based developer of therapeutic and preventative approaches to autoimmune and inflammatory diseases, has raised €18 million in Series B funding. Participants included Novartis Venture Fund, Fountain Healthcare Partners, Inventages Venture Capital and Seroba Kernel Life Sciences.
18 February 2009•4 mins read
